While GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) face challenges in sustained weight control and muscle preservation, CG-0416 employs precision targeting of complementary metabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback